NeoRx
NeoRx was engaged in the research and development of products for targeted delivery of anti-cancer agents, including radiopharmaceuticals, directly to sites of disease. It was acquired by Poniard Pharmaceuticals, Inc.
NeoRx was engaged in the research and development of products for targeted delivery of anti-cancer agents, including radiopharmaceuticals, directly to sites of disease. It was acquired by Poniard Pharmaceuticals, Inc.